Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOPE-75 RCT: Low- and Moderate-Intensity Statin for Primary Prevention in Adults Over 75 Years
KCT0003629Phase 4Terminated
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of ulinastatin in cardiac morbidity, sponsored by Samjin Pharmaceutical Co., Ltd.. Started Apr 2019; status: terminated.
02
Drugs
ulinastatin
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on KCT0003629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003629.